Nivolumab Added to Cisplatin-Radiotherapy Versus Cisplatin-Radiotherapy Alone after Surgery for Patients with Squamous Cell Carcinoma of the Head and Neck at High-Risk of Relapse (GORTEC 2018-01 NIVOPOST-OP): A Randomised, Open-Label, Phase 3 Trial | Publicación